This episode features Kris Blohm and Courtney Midanek, Managing Directors and Co-Practice Leads for Mergers and Acquisitions at Kaufman Hall, as they explore how health systems can use a holistic, data-driven approach to assess operations, optimize service lines, and drive long-term success.

Kaufman Hall’s 2025 Summer Rating Agency Update offered an early look at how the newly enacted One Big Beautiful Bill (OBBB) could reshape hospital credit profiles.

Net patient revenue per provider increased overall, and physician productivity continues to rise.

Hospital revenue on a volume adjusted basis increased. However, bad debt rose in June compared to May, outpacing the growth rate of previous months.

This week’s graphic features data from Vizient’s Summer 2025 Spend Management Outlook, which provides a forward-looking analysis of product cost inflation for the 2026 calendar year.

HHS cancels mRNA contracts, insurance troubles create an opening for IDNs, Gates Foundation announces major women’s health initiative.

With its acquisition of AMSURG, a national ambulatory chain, Ascension is changing the playbook for not-for-profit business model transformation. The acquisition raises important questions: How do we expect the game to be played moving forward, and how do we want to participate?

On this episode of the Gist Healthcare Podcast, host J. Carlisle Larsen is joined by CHAI CEO Brian Anderson, MD, about the partnership and themes that are already emerging from these early conversations.

This week’s graphic features data from a KFF analysis of how prevalent immigrants are in the hospital workforce.

UnitedHealth’s difficulties continue, more doctors exit traditional Medicare, troubling new report on hospital safety reporting

Primary care alignment remains essential, but employment is only one tool in the toolbox. Health systems facing mounting losses, shifting patient populations or rising competition from disruptive entrants should consider whether a different model might better serve their mission, physicians and patients.

Watch our recent Rating Agency panel discussion featuring colleagues from Moody’s, S&P and Fitch. Hear the latest industry outlooks, rating activity through early 2025 and what this means for the healthcare sector.